Obesity drugs could bankrupt US healthcare, says Sanders
A report issued by the office of US Senator Bernie Sanders has claimed that the high prices being charged for new GLP-1 agonist-based obesity therapies like Novo Nordisk’s Wegovy could end up bankrupting US healthcare systems. Staff in the Senate Health, …